Press Releases

Month Year

Month Year

Aug 31, 2005

Strong growth in 2005 first half adjusted EPS : up 26.1% at €2.22. Increase in full year adjusted EPS guidance. Positive phase IIb/III results for 6 products
Aug 18, 2005

Taxotere® Significantly Improves Survival Compared with paclitaxel In Women With Advanced Breast Cancer
Aug 15, 2005

The U.S. Food and Drug Administration approves ACTONEL® WITH CALCIUM
Aug 2, 2005

Sanofi-aventis Issues Strong Support for Voluntary “Guiding Principles” on DTC Advertising
Jul 27, 2005

ALLEGRA-D® 24 HOUR (fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg) EXTENDED RELEASE TABLETS NOW AVAILABLE FOR SEASONAL ALLERGY SUFFERERS
Jul 19, 2005

Strong net sales growth in the first half of 2005: 11.0% on a comparable basis - Further increase in market share in the second quarter
Jun 30, 2005

Sports Legend Tony Gwynn Teams up with Former Baseball Champions to Raise Awareness of Deep-Vein Thrombosis (DVT) in the National Educational Campaign, "DVT Blood Clots: Know The Stats. Know Your Risk.”
Jun 28, 2005

PANEL OF EXPERTS AGREE THAT BONE MINERAL DENSITY IS NO LONGER ENOUGH
Jun 23, 2005

RIMONABANT ACCEPTED FOR FILING BY THE FDA
Jun 14, 2005

Data presented at American Diabetes Association Scientific Sessions support Exubera® Efficacy and Safety Profile in Type 1 and Type 2 Diabetes

Show per page

Print
Email page
RSS